Clarus Ventures, LLC Q2 2018 vs. Q3 2018: Analyzing Changes in 13F Holdings

Clarus Ventures, LLC is a global investment firm that focuses on the life sciences industry, specifically pharmaceuticals, biotechnology, and medical device companies. As with any investment firm, Clarus Ventures, LLC is required by law to file a Form 13F with the Securities and Exchange Commission (SEC) every quarter. The Form 13F discloses the firm's holdings of publicly traded securities, which helps provide insight into the investments made by Clarus Ventures, LLC and other investment firms.

In this article, we will examine the changes in Clarus Ventures, LLC's 13F holdings from Q2 2018 to Q3 2018. We will analyze the top holdings and discuss notable increases and decreases in the portfolio.

Top Holdings

According to the Q3 2018 13F filing, Clarus Ventures, LLC's top holdings include AvroBio Inc. (AVRO), Nanostring Technologies Inc. (NSTG), Sientra Inc. (SIEN), and Forty Seven Inc. (FTSV).

AvroBio Inc. remained the top holding with 2,962,325 shares, equal to the Q2 2018 share count. However, the value of the shares increased significantly from $84,604,000 to $153,656,000, indicating a significant increase in the stock's price during Q3 2018.

Notable Increases

Nanostring Technologies Inc. saw a notable increase in shares held from 3,959,440 in Q2 to 4,036,025 in Q3, representing a 1.93% increase. The value of the shares also increased from $54,165,000 to $71,962,000, a 32.9% increase.

Sientra Inc. had an increase of 1.53% in shares held, staying at 2,730,765. The value of these shares increased by 22.4% from $53,277,000 to $65,211,000.

Notable Decreases

Gritstone Oncology Inc. (GRTS) saw a decrease in shares held from 3,816,951 in Q2 to 2,567,445 in Q3, representing a decrease of 32.7%. The value of the shares also decreased from $61,071,000 to $56,949,000, indicating a decrease in the stock's price during Q3 2018.

Entasis Therapeutics Holdings Inc. (ETTX) had a decrease in shares held from 1,623,405 in Q2 to 0 in Q3. The value of the shares was also 0 in both Q2 and Q3.

Restoration Robotics Inc. (VERO) had a decrease in value from $12,387,000 in Q2 to $10,353,000 in Q3, indicating a decrease in the stock's price during Q3 2018.

Conclusion

Overall, Clarus Ventures, LLC's portfolio saw some notable changes in Q3 2018 compared to Q2 2018. While some holdings remained steady, others saw significant increases or decreases in shares held or value. As always, it is important to note that past performance is not indicative of future results and that these changes should only be viewed as a snapshot of Clarus Ventures, LLC's portfolio as of Q3 2018. Investors should always do their own research and consult with a financial advisor before making any investment decisions.